Park Square Places Brian Stephenson, Ph.D., C.F.A., as Chief Financial Officer at Faeth Therapeutics
Park Square Executive Search is pleased to announce the placement of Brian Stephenson, Ph.D., C.F.A., as Chief Financial Officer at Faeth...
Park Square Executive Search is pleased to announce the placement of Brian Stephenson, Ph.D., C.F.A., as Chief Financial Officer at Faeth...
So pleased for my friend Mathai Mammen, founder Greg Verdine, and all of Parabilis Medicines on this remarkable milestone!
Parabilis Medicines said it would sell 33.5 million shares at $20 apiece, for a total of $670 million.
Park Square has placed John Maraganore as Advisor at Oak HC/FT.
Few leaders in biotechnology have successfully willed an entirely new class of medicine into existence, but Oak’s newest advisor, John...…
Park Square has placed Srikanth Pendyala, M.D. as Chief Medical Officer at Infinimmune.
Infinimmune, a biotechnology company pioneering antibody discovery and design, today announced the appointment of Srikanth Pendyala,...…
Park Square has placed Donn Casale as President of ARS Pharmaceuticals.
ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering patients and their caregivers to better...…
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net